Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study

Journal:
Blood
Published:
Affiliations:
23
Authors:
33
Institutions Authors Share
Sapienza University of Rome, Italy
6.500000
0.20
GIMEMA Foundation, Italy
4.000000
0.12
Azienda Ospedaliera Papa Giovanni XXIII, Italy
3.000000
0.09
Ospedale dell'Angelo Mestre, Italy
2.000000
0.06
Azienda sanitaria universitaria Friuli Centrale (ASU FC), Italy
1.500000
0.05
United Hospitals Villa Sofia-Cervello, Italy
1.000000
0.03
Careggi University Hospital (AOUC), UNIFI, Italy
1.000000
0.03
University of Milan (UNIMI), Italy
1.000000
0.03
Antonio Cardarelli Hospital, Italy
1.000000
0.03
IRCCS Policlinico San Matteo, Italy
1.000000
0.03
Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Italy
1.000000
0.03
Plesso Ospedaliero Andrea Tortora, Italy
1.000000
0.03
Siena University Hospital, Italy
1.000000
0.03
Policlinico Universitario di Catania, Italy
1.000000
0.03
University of Naples Federico II (UNINA), Italy
1.000000
0.03
San Bortolo Hospital, Italy
1.000000
0.03
A.O.U. Citta della Salute e della Scienza di Torino, Italy
1.000000
0.03
University of Eastern Piedmont "Amedeo Avogadro" (UPO), Italy
1.000000
0.03
Ospedale degli Infermi, Italy
1.000000
0.03
Associazione Italiana Leucemie Roma OdV (AIL ROMA), Italy
0.500000
0.02
Catholic University of the Sacred Heart (UCSC), Italy
0.500000
0.02
Agostino Gemelli University Polyclinic, Italy
0.500000
0.02
University of Modena and Reggio Emilia (UNIMORE), Italy
0.500000
0.02